Immunohistochemical features of a papillary squamous cell carcinoma of the endometrium with transitional cell differentiation

Diagnostic Pathology

Volumn 2, Issue 1, 2007, Pages

  Ribeiro Silva, Alfredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547903858     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-2-26     Document Type: Article

References (13)

1. Rodolakis A, Papaspyrou I, Sotiropoulou M, Markaki S, Michalas S: Primary squamous cell carcinoma of the endometrium. A report of 3 cases. Eur J Gynaecol Oncol 2001, 22:143-146.
2. Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA: Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation. Cancer 1997, 79:1933-1943.
3. Labonté S, Têtu B, Boucher D, Larue H: Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: a case report. Hum Pathol 2001, 32:230-232.
4. Aikins JK, Gisser S, Qasim S, Saul H, Rocereto T: Primary squamous cell carcinoma of the endometrium, Int J Gynaecol Obstet 1995, 50:55-60.
5. Mirhashemi R, Ganjei-Azar P, Nadji M, Lambrou N, Atamdede F, Averette HE: Papillary squamous cell carcinoma of the uterine cervix: an immunophenotypic appraisal of 12 cases. Gynecol Oncol 2003, 90:657-661.
6. Stefansson IM, Salvesen HB, Akslen LA: Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. Int j Cancer 2006, 118:1227-1233.
7. Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T, Konishi I: Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 2003, 34:471-478.
8. Alkushi A, Irving J, Hsu F, Dupuis B, Liu CL, Rijn M, Gilks CB: Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003, 442:271-277.
9. Milde-Langosch K, Bamberger AM, Goemann C, Rössing E, Rieck G, Kelp B, Löning T: Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol 2001, 127:537-544.
10. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK: Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 2003, 9:1361-1369.
11. Masciullo V, Susini T, Zamparelli A, Bovicelli A, Minimo C, Massi D, Taddei G, Maggiano N, De laco P, Ceccaroni M, Bovicelli L, Amunni G, Mancuso S, Scambia G, Giordano A: Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kipl) in estrogen-related Endometrial adenocarcinomas. Clin Cancer Res 2003, 9:5332-5338.
12. Mitselou A, loachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ: Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. In Vivo 2003, 17:469-477.
13. Peiró G, Dieboldj, Baretton GB, Kimmig R, Löhrs U: Cellularapoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol 2001, 20:359-367.